In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Benedict Albensi Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Benedict
Last Name:Albensi
Title:Associate Professor (Principal Invest)
Advanced Degrees:PhD
Affiliation:University of Manitoba
Department:Pharmacology and Therapeutics
Street Address 1:351 Tache Ave/Lab 4050
Street Address 2:St Boniface Research Centre
City:Winnipeg
State/Province:Manitoba
Zip/Postal Code:R2H 2A6
Country/Territory:Canada
Phone:204/235-3942
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 19 January 2013]
Clinical Interests:
Aging Process, Alzheimer Disease, Stroke and Trauma
Research Focus:
Molecular and Cell biology, Neuropathology, Signal transduction, Electrophysiology, Genetics, Apoptosis/Cell cycle, Clinical trials, Oxidative Stress, Proteomics, Synaptic plasticity, Neurobiology, Chemistry/Pharmacology, Tau/Cytoskeleton, Microscopy, Drug screening, Diagnosis, DNA microarrays, A-beta PP/A-beta, Neurotransmission, Brain imaging, Animal Models
Work Sector(s):
Research institute, Medical hospital, University
Web Sites:
Professional: www.sbrc.ca/dnd
Lab: http://www.sbrc.ca/dnd/
Researcher Bio
My laboratory is focused on understanding the biological basis of memory. In addition, we study NF-kB signaling pathways that play a roll not only in normal memory, but also in Alzheimer's disease. Current and/or Past manuscripts/studies include:

* The role of creatine and mitochondrial dysfunction in memory impairment in AD
* NF-kB p50 subunit knock out leads to impairments in LTP and memory (MWM)
* The role of presenilin mutations in synaptic plasticity and Alzheimer's disease
* Hypoxia-ischemia in the neonatal vs. adult hippocampus
* Temporal evolution of traumatic brain injury (TBI) in the adult hippocampus
* Distribution of N-type calcium channels in human and rat hippocampus
* Mitochondrial membrane permeability transition, TBI, and hippocampal synaptic plasticity
* Tumor necrosis factor and hippocampal synaptic plasticity
* Spider toxins, NMDA/AMPA-receptor mediated transmission, and hippocampal synaptic plasticity
* Suppression of epileptiform activity by prolonged electrical stimulation in the hippocampus

Prior investigations have also attempted to identify therapeutic targets (glutamate receptors, oxidative stress intermediates, cytokines, and ionic channels) in CNS diseases and pathology such as in dementia, stroke, head trauma, and processes of aging, etc. This has included work with natural products for drug discovery.
Top Papers
B.C. ALBENSI and M.P. Mattson. Evidence for the Involvement of TNF and NF-kB in Hippocampal Synaptic Plasticity. Synapse 35: 151-159, 2000.

B.C. ALBENSI, S. Knoblach, B.G.M. Chew, M.P. O'Reilly, A.I. Faden and J.J. Pekar. Diffusion and High Resolution MRI of Traumatic Brain Injury in Rats: Time Course and Correlation with Histology. Exp Neurol 162: 61-72, 2000.

B.C. ALBENSI, P. Sullivan, M. Thompson, S. Scheff and M.P. Mattson. Cyclosporin Ameliorates Traumatic Brain Injury-Induced Alterations of Hippocampal Synaptic Plasticity Exp Neurol 162(2):385-389, 2000.

N. Marchi, P. Rasmussen, M. Kapural, V. Fazio, K. Kight, M.R. Mayberg, A. Kanner, B. Ayumar, B.C. ALBENSI, M. Cavaglia, D. Janigro. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci 21(3,4):109-121, 2003

B.C. ALBENSI, E. Ilkanich, G. Dini and D. Janigro. Elements of Scientific Visualization in Basic Neuroscience Research. BioScience 54(12): 1127-1137, 2004. Review.

J. Thiessen, K.A.C. Glazner, S. Nafez, A. Schellenberg, R. Buist, M. Martin, and B.C. ALBENSI. Histochemical visualization and diffusion weighted imaging in the TgCRND8 transgenic model of Alzheimer’s disease. Brain Structure and Function 215(1): 29-36, 2010.

D. Zhang, R. Buist, W. Xiong, J. Peeling, B.C. ALBENSI, F.E. Parkinson. Expression of human equilibrative nucleoside transporter 1 (hENT1) in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions. Journal of Neurochemistry 118(1):4-11, 2011.

M.Z. Kastyak-Ibrahim, M.J. Nasse, M. Rak, C. Hirschmugl, M.R. Del Bigio, B.C. ALBENSI and K.M. Gough. Biochemical label-free tissue imaging with subcellular-resolution synchrotron FTIR-FPA. NeuroImage 60: 376–383, 2012.

K. Oikawa, G.L. Odero, E. Platt, M. Neuendorff, A. Hatherell, M.J. Bernstein, and B.C. ALBENSI. NF-kB p50 Subunit Knockout Impairs Late LTP and Alters Long Term Memory in the Mouse Hippocampus. BMC Neuroscience 13:45, 2012. Noted as “Highly Accessed” by publisher on Oct 10, 2012 (989 times).

D. Zhang, S. Chu, C. Sun, W. Xiong, B.C. ALBENSI, F. E. Parkinson. Inhibition of synaptic activity in hippocampus by ATP, hypoxia or oxygen-glucose deprivation does not require CD73. PloS One. Accepted May 2012 (PONE-D-12-08114R1).
What is the greatest void to date in our knowledge of Alzheimer's Disease?
One very important pathological consideration is the link between Amyloid beta deposition and the hyperphosphorylation of tau proteins that lead to tangles. We do not know how this occurs.
What are the top three papers (not yours) you have read recently?


If resources were not limited, what research projects would you pursue?
1) how to improve mitochondrial function and cellular energetics

2) how to reduce inflammatory respones in AD

3) how to reduce oxidative stress
What is your leading hypothesis?
The most interesting hypothesis of late in my mind has to do with deficits in cellular energetics and the establishment of AD.
What piece of missing evidence would help prove it?
If we could reverse cognitive deficits by improving mitochondrial function over the long term.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad